| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 07/18/2007 | EP1807424A2 Novel kinase inhibitors |
| 07/18/2007 | EP1807419A1 (2-carboxamido)(3-amino) thiophene compounds |
| 07/18/2007 | EP1807415A2 Novel anthranilamide pyridinureas as vegf receptor kinase inhibitors |
| 07/18/2007 | EP1807412A1 Cyclic diarly ureas suitable as tyrosine kinase inhibitors |
| 07/18/2007 | EP1807410A1 Compounds and compositions useful in the treatment of neoplasia |
| 07/18/2007 | EP1807407A1 Aromatic amides as inhibitors of c-fms kinase |
| 07/18/2007 | EP1807402A1 Quinazoline derivatives, process for their preparation, their use as antimitotics and pharmaceutical compositions comprising said derivatives |
| 07/18/2007 | EP1807386A1 Novel compounds useful for modulating abnormal cell proliferation |
| 07/18/2007 | EP1807115A1 Nanoparticles comprising an intracellular targeting element and preparation and use thereof |
| 07/18/2007 | EP1807096A1 Bioactive polymers |
| 07/18/2007 | EP1807079A1 Treatment of osteoarthritis and dosing regimen for arzoxifene |
| 07/18/2007 | EP1807077A2 Inhibitors of c-fms kinase |
| 07/18/2007 | EP1807074A1 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 07/18/2007 | EP1807051A2 Compositions and methods for stabilizing liposomal camptothecin formulations |
| 07/18/2007 | EP1373224B1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors |
| 07/18/2007 | EP1007044B1 Quinazolinone-containing pharmaceutical compositions for prevention of neovascularization and for treating malignancies |
| 07/18/2007 | EP0770140B1 Composition containing nucleic acids and cationic polymers, preparation and uses |
| 07/18/2007 | CN1327000C Shuttle vector of repeatable adenovirus of targeting melanoma and adenovirus |
| 07/18/2007 | CN1326881C Trivalent bispecific antibody and its preparation process and use |
| 07/18/2007 | CN1326877C Specific antibody fragments for the human carcinoembryonic antigen (CEA) |
| 07/18/2007 | CN1326875C Tumor antigen protein and tumor antigen peptide |
| 07/18/2007 | CN1326867C Process for united separation and purification of ursolic acid and oligomeric proanthocyanidin and application thereof |
| 07/18/2007 | CN1326850C Tricyclic farnesyl protein transferase inhibitors |
| 07/18/2007 | CN1326847C Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
| 07/18/2007 | CN1326841C Arylalkane-sulfonamides having endothelin-antagonist activity |
| 07/18/2007 | CN1326823C Cyclic alcohol derivative keratinous sponge alcohol, and its preparing method and use |
| 07/18/2007 | CN1326577C N-{5-[4-(4-methyl-piperazino-methyl)--benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 07/18/2007 | CN1326569C Pharmaceutical formulation of IRESSA comprising a water-soluble cellulose derivative |
| 07/18/2007 | CN1326566C Immunotherapeutic combinations for the treatment of tumors |
| 07/18/2007 | CN1326565C Potentiator for antibody against lymphoid tumor |
| 07/18/2007 | CN1326554C Antitumour medicine |
| 07/18/2007 | CN1326551C Therapy assisting agent for malignancy and its preparation method |
| 07/18/2007 | CN1326538C Pain relieving cancer treating decoction and its preparation method |
| 07/18/2007 | CN1326531C Health care tea for preventing cancer, lowering blood fat and lowering blood pressure |
| 07/18/2007 | CN1326530C Method for extracting spore oil from exosporium-broken spore of glossy ganoderma |
| 07/18/2007 | CN1326528C Process for preparing arsenic magnetized nanometer glutin minipill |
| 07/18/2007 | CN1326525C 10-hydroxy camptothecin long cyclic liposome and its freeze aried preparation |
| 07/18/2007 | CN1326523C Atineoplastic combinations |
| 07/18/2007 | CN1326521C Use for 3-indole aldehydes and its derivatives in preparation of anti-tumour medication |
| 07/18/2007 | CN101001869A Carcinoembryonic antigen fusions and uses thereof |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001834A Nonpeptide inhibitors of matrix metalloproteinases |
| 07/18/2007 | CN101001646A Stabilized synthetic immunogen delivery system |
| 07/18/2007 | CN101001640A 缓释组合物 Sustained release composition |
| 07/18/2007 | CN101001629A Medicinal composition |
| 07/18/2007 | CN101001623A Anticancer effect enhancer |
| 07/18/2007 | CN101001617A Antitumor agent |
| 07/18/2007 | CN101001609A Method of manufacturing pharmaceutical preparations containing liposomes |
| 07/18/2007 | CN101001608A Galenic applications of self-emulsifying mixtures of lipidic excipients |
| 07/18/2007 | CN100999734A Application in adenovirus expression carrier of humen immunoglobulin storter |
| 07/18/2007 | CN100999727A Tumor and immune related regulating and controlling gene caspase-10/G |
| 07/18/2007 | CN100999527A Selenaza aromatic heterocyclic compound with anti-tumor activty and its preparation process and application |
| 07/18/2007 | CN100999524A Taxad phenol derivate with anti-tumor activity |
| 07/18/2007 | CN100999520A Isoandrographolide analogue and its preparation process |
| 07/18/2007 | CN100999503A Hexanary carbocycle azole like nucleoside analogue, its synthesizing process and use in anti virus and tumor thereof |
| 07/18/2007 | CN100999501A Process for the preparation of 2-methyl piperazine derivatives |
| 07/18/2007 | CN100999494A Compound with action of anti-HIV and malignant tumour and its preparation process and use |
| 07/18/2007 | CN100999492A Quinoline kind iriyellowsin electronic isostericmer its preparation process and use |
| 07/18/2007 | CN100998870A Stable polymer micelle medicine carrging system |
| 07/18/2007 | CN100998869A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998868A Antientity tumour composition |
| 07/18/2007 | CN100998867A Anticancer Chinese medicine compound nanometer emulsion and its preparation method |
| 07/18/2007 | CN100998819A Chinese medicinal compound preparation for inhibiting tumour and anti-insenescence |
| 07/18/2007 | CN100998805A Biporia strengthening the body resistance anticancer preparation and its preparation method |
| 07/18/2007 | CN100998775A Traditional Chinese medicine prescription for treating cancer |
| 07/18/2007 | CN100998769A Chinese medicine decoction for anti-cancer and strengthening the body resistance |
| 07/18/2007 | CN100998766A Traditional Chinese medicine for treating mammary gland cancer, hysteromyoma and cavernous tumor |
| 07/18/2007 | CN100998631A Medicine form of low toxin thunder godvine extract by using new processing method |
| 07/18/2007 | CN100998626A Method for preparing extract of korea thistle leaf |
| 07/18/2007 | CN100998611A Huishuhua fermentation preparation process using Chinese herb medicine as medium |
| 07/18/2007 | CN100998591A Anticancer composition containing Epomycin and vasoinhibitor |
| 07/18/2007 | CN100998589A Novel use of Enduotai, hard capsule thereof, and method for preparing the injection |
| 07/18/2007 | CN100998584A Medicine composition used for injection and its preparing method |
| 07/18/2007 | CN100998573A Effect and use of capusle prepared by blending multiple sola-red-agent |
| 07/18/2007 | CN100998566A Nanometer microsphere of temozolomide polylactic acid and its preparation and preparing method therefor |
| 07/18/2007 | CN100998565A Anti-angiogene compositions and methods of use |
| 07/18/2007 | CN100998563A Magnetic pegylated liposomal doxorubicin and preparation method and application |
| 07/18/2007 | CN100998562A Preparation of vinorelbine lipoplast, for injection |
| 07/18/2007 | CN100998560A Frozen emulsion containing polyene paclitaxel and its preparing method |
| 07/18/2007 | CN100998559A Submicroemulsion injection containing polyene paclitaxel and its preparing method |
| 07/18/2007 | CN100998558A Slow-release anticarcinogen contg. carmustine and fluorouracil |
| 07/18/2007 | CN100998557A Water type injection containing paclitaxel and its preparing method |
| 07/18/2007 | CN100998555A Slow-release anticarcinogen containing vasoinhibitor |
| 07/18/2007 | CN100998554A Slow-release medicine for anti-solid tumor |
| 07/18/2007 | CN100998553A Compound anticarcinogen slow-release preparation containing vasoinhibitor |
| 07/18/2007 | CN100998552A Composition of oral medicine preparation and its preparing method |
| 07/18/2007 | CN100998313A Production method of ginseng culture root extraction with high content of ginsenoside and its use |
| 07/17/2007 | US7244855 In presence of acidic clay; coupling in presenc eof silver tetrafluoroborate ; anticancer agents |
| 07/17/2007 | US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244762 Antitumoral d-homoestra-1,3,5 (10)-trien-3-yl 2-substituted sulfamates |
| 07/17/2007 | US7244760 Methods for preparation and use of psorospermin analogs |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244752 Broadspectrum 2-(substituted-amino)-benzoxazole sulfonamide HIV protease inhibitors |
| 07/17/2007 | US7244751 N-(2-amino-5-fluorophenyl)-4-[N-(Pyridn-3-ylacryloyl)aminomethyl]benzamide or other derivatives for treating cancer and psoriasis |
| 07/17/2007 | US7244741 Fredericamycin derivatives as medicaments for treating tumours |
| 07/17/2007 | US7244733 N-(4-Chlorophenyl)pyrrolo[2,1-f][1,2,4]triazin-4-amine for example; inhibit the tyrosine kinase activity of growth factor receptors such as VEGFR-2, FGFR-1; angiogenesis inhibitors; anticancer agents; diseases associated with signal transduction pathways operating through growth factor receptors |
| 07/17/2007 | US7244730 Thrombin receptor antagonists; safety, specificity, oral efficacy |
| 07/17/2007 | US7244729 tyrosine kinase inhibitors; for the treatment especially of a proliferative disease, such as a tumur |
| 07/17/2007 | US7244723 Kinesin spindle protein (KSP) inhibitors, e.g., 3-benzyl-2-(1-{(4-bromobenzyl)[2-(dimethylamino)ethyl]amino}propyl)furo[2,3-d]pyrimidin-4(3H)-one; antiproliferative and -carcinogenic agents; side effects reduction; cancers of the brain, genitourinary tract, lymphatic system, stomach, larynx and lung |